Correction: Serum 25-hydroxyvitamin D concentrations 40 ng/ml are associated with >65% lower cancer risk: Pooled analysis of randomized trial and prospective cohort study (PLoS ONE (2016) 11: 4 (e0152441) DOI: 10.1371/journal.pone.0152441);Serum 25-hydroxyvitamin d concentrations ≥40 ng/ml are associated with >65% lower cancer risk: Pooled analysis of randomized trial and prospective cohort study

PLoS ONE

Volumn 11, Issue 4, 2016, Pages

  McDonnell, Sharon L ^a   Baggerly, Carole ^a   French, Christine B ^a   Baggerly, Leo L ^a   Garland, Cedric F ^b   Gorham, Edward D ^b   Lappe, Joan M ^c   Heaney, Robert P ^c  

^a GrassrootsHealth   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; VITAMIN D;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER RISK; COHORT ANALYSIS; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NUTRITIONAL STATUS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; VITAMIN BLOOD LEVEL; ANALOGS AND DERIVATIVES; BLOOD; CONTROLLED STUDY; INCIDENCE; MIDDLE AGED; NEOPLASMS; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

AGED; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; NEOPLASMS; PROSPECTIVE STUDIES; RISK FACTORS; VITAMIN D;

EID: 84962840858     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0201078     Document Type: Erratum

References (35)

1. National Cancer Institute (NCI). Cancer Statistics. Available at: www.cancer.gov/about-cancer/what-iscancer/statistics. Accessed February 23, 2016.
2. Garland CF, Garland FC. Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol. 1980 Sep; 9(3):227-31. PMID: 7440046
3. Lowe LC, Guy M, Mansi JL, Peckitt C, Bliss J, Wilson RG, et al. Plasma 25-hydroxy vitamin D concentrations, vitamin D receptor genotype and breast cancer risk in a UK Caucasian population. Eur J Cancer. 2005 May; 41(8):1164-9. PMID: 15911240
4. Abbas S, Linseisen J, Slanger T, Kropp S, Mutschelknauss EJ, Flesch-Janys D, et al. Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer-results of a large case-control study. Carcinogenesis. 2008 Jan; 29(1):93-9. PMID: 17974532
5. Bilinski K, Boyages J. Association between 25-hydroxyvitamin D concentration and breast cancer risk in an Australian population: an observational case-control study. Breast Cancer Res Treat. 2013 Jan; 137(2):599-607. doi: 10.1007/s10549-012-2381-1 PMID: 23239153
6. Yao S, Sucheston LE, Millen AE, Johnson CS, Trump DL, Nesline MK, et al. Pretreatment serum concentrations of 25-hydroxyvitamin D and breast cancer prognostic characteristics: a case-control and a case-series study. PLoS One. 2011 Feb. 28;6(2):e17251. doi: 10.1371/journal.pone.0017251 PMID: 21386992
7. Abbas S, Chang-Claude J, Linseisen J. Plasma 25-hydroxyvitamin D and premenopausal breast cancer risk in a German case-control study. Int J Cancer. 2009 Jan 1;124(1):250-5. doi: 10.1002/ijc.23904 PMID: 18839430
8. Rejnmark L, Tietze A, Vestergaard P, Buhl L, Lehbrink M, Heickendorff L, et al. Reduced prediagnostic 25-hydroxyvitamin D levels in women with breast cancer: a nested case-control study. Cancer Epidemiol Biomarkers Prev. 2009 Oct; 18(10):2655-60. doi: 10.1158/1055-9965. EPI-09-0531 PMID: 19789365
9. Crew KD, Gammon MD, Steck SE, Hershman DL, Cremers S, Dworakowski E, et al. Association between plasma 25-hydroxyvitamin D and breast cancer risk. Cancer Prev Res (Phila). 2009 Jun; 2(6):598-604.
10. Peppone LJ, Rickles AS, Janelsins MC, Insalaco MR, Skinner KA. The association between breast cancer prognostic indicators and serum 25-OH vitamin D levels. Ann Surg Oncol. 2012 Aug; 19(8):2590-9. doi: 10.1245/s10434-012-2297-3 PMID: 22446898
11. Gorham ED, Garland CF, Garland FC, Grant WB, Mohr SB, Lipkin M, et al. Vitamin D and prevention of colorectal cancer. J Steroid Biochem Mol Biol. 2005 Oct; 97(1-2):179-94. PMID: 16236494
12. Chandler PD, Buring JE, Manson JE, Giovannucci EL, Moorthy MV, Zhang S, et al. Circulating Vitamin D Levels and Risk of Colorectal Cancer in Women. Cancer Prev Res (Phila). 2015 Aug; 8(8):675-82.
13. Shui IM, Mucci LA, Kraft P, Tamimi RM, Lindstrom S, Penney KL, et al. Vitamin D-related genetic variation, plasma vitamin D, and risk of lethal prostate cancer: a prospective nested case-control study. J Natl Cancer Inst. 2012 May 2;104(9):690-9. doi: 10.1093/jnci/djs189 PMID: 22499501
14. Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr. 2007 Jun; 85(6):1586-91. PMID: 17556697
15. Lappe JM, Davies KM, Travers-Gustafson D, Heaney RP. Vitamin D status in a rural postmenopausal female population. J Am Coll Nutr. 2006;25:395-402. PMID: 17031008
16. Garland CF, French CB, Baggerly LL, Heaney RP. Vitamin D supplement doses and serum 25-hydroxyvitamin D in the range associated with cancer prevention. Anticancer research. 2011;31(2):607-11. PMID: 21378345
17. Eyles D, Anderson C, Ko P, Jones A, Thomas A, Burne T, et al. A sensitive LC/MS/MS assay of 25OH vitamin D (3) and 25OH vitamin D (2) in dried blood spots. Clin Chim Acta. 2009;403(1-2):145-151. doi: 10.1016/j.cca.2009.02.005 PMID: 19232332
18. Van den Broeck J, Brestoff JR. Epidemiology: Principles and Practical Guidelines (pp. 455). Dordrecht: Springer, 2013.
19. Rothman KJ, Greenland S, Lash T. Modern Epidemiology: Third Edition (pp. 321). Philadelphia, PA: Lippincott-Raven, 1998.
20. Selvin S. Statistical Tools for Epidemiologic Research (pp. 258-260). Oxford: Oxford University Press, 2011.
21. National Academy of Sciences-Institute of Medicine-Food and Nutrition Board. Dietary reference intakes for calcium and vitamin D. Washington (DC): National Academy Press; 2010.
22. Garland CF, Gorham ED, Mohr SB, Garland FC. Vitamin D for cancer prevention: global perspective. Ann Epidemiol. 2009 Jul; 19(7):468-83. doi: 10.1016/j.annepidem.2009.03.021 PMID: 19523595
23. Holick MF. Vitamin D, sunlight and cancer connection. Anticancer Agents Med Chem. 2013 Jan; 13(1):70-82. PMID: 23094923
24. Cannell JJ, Hollis BW, Zasloff M, Heaney RP. Diagnosis and treatment of vitamin D deficiency. Expert Opin Pharmacother. 2008 Jan; 9(1):107-18. PMID: 18076342
25. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr. 2006 Jul; 84(1):18-28. PMID: 16825677
26. Souberbielle JC, Body JJ, Lappe JM, Plebani M, Shoenfeld Y, Wang TJ, et al. Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. Autoimmun Rev. 2010 Sep; 9(11):709-15. doi: 10.1016/j.autrev. 2010.06.009 PMID: 20601202
27. Heaney RP. Guidelines for optimizing design and analysis of clinical studies of nutrient effects. Nutr Rev. 2014 Jan; 72(1):48-54. doi: 10.1111/nure.12090 PMID: 24330136
28. Wactawski-Wende J, Kotchen JM, Anderson GL, Assaf AR, Brunner RL, O'Sullivan MJ, et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med. 2006;354:684-696. PMID: 16481636
29. Neuhouser ML, Manson JE, Millen A, Pettinger M, Margolis K, Jacobs ET, et al. The influence of health and lifestyle characteristics on the relation of serum 25-hydroxyvitamin D with risk of colorectal and breast cancer in postmenopausal women. Am J Epidemiol. 2012 Apr. 1;175(7):673-84. doi: 10.1093/aje/kwr350 PMID: 22362582
30. Cheng TY, Lacroix AZ, Beresford SA, Goodman GE, Thornquist MD, Zheng Y, et al. Vitamin D intake and lung cancer risk in the Women's Health Initiative. Am J Clin Nutr. 2013 Oct; 98(4):1002-11. doi: 10. 3945/ajcn. 112.055905 PMID: 23966428
31. Wolpin BM, Ng K, Bao Y, Kraft P, Stampfer MJ, Michaud DS, et al. Plasma 25-hydroxyvitamin D and risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev. 2012 Jan; 21(1):82-91. doi: 10.1158/1055-9965. EPI-11-0836 PMID: 22086883
32. Slominski AT, Kim TK, Shehabi HZ, Semak I, Tang EK, Nguyen MN, et al. In vivo evidence for a novel pathway of vitamin D3 metabolism initiated by P450scc and modified by CYP27B1. FASEB J. 2012 Sep; 26(9):3901-3915. doi: 10.1096/fj.12-208975 PMID: 22683847
33. Slominski AT, Li W, Kim TK, Semak I, Wang J, Zjawiony JK, et al. Novel activities of CYP11A1 and their potential physiological significance. J Steroid Biochem Mol Biol. 2015 Jul; 151:25-37. doi: 10. 1016/j.jsbmb.2014.11.010 PMID: 25448732
34. Slominski AT, Kim TK, Li W, Postlethwaite A, Tieu EW, Tang EK, et al. Detection of novel CYP11A1-derived secosteroids in the human epidermis and serum and pig adrenal gland. Sci Rep. 2015 Oct; 5:14875. doi: 10.1038/srep14875 PMID: 26445902
35. Zhang L, Wang S, Che X, Li X. Vitamin D and lung cancer risk: a comprehensive review and meta-analysis. Cell Physiol Biochem. 2015;36(1):299-305. doi: 10.1159/000374072 PMID: 25967968